Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions
- PMID: 32499036
- DOI: 10.1016/j.jaip.2020.04.002
Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions
Comment on
-
Risk for Anaphylactic Reaction from Cardiac Catheterization in Patients Receiving β-Adrenergic Blockers or Angiotensin-Converting Enzyme-Inhibitors.J Allergy Clin Immunol Pract. 2020 Jun;8(6):1900-1905. doi: 10.1016/j.jaip.2019.10.020. Epub 2019 Nov 1. J Allergy Clin Immunol Pract. 2020. PMID: 31683029